Azithromycin Reduction to Reach Elimination of Trachoma
Status:
Recruiting
Trial end date:
2027-01-31
Target enrollment:
Participant gender:
Summary
The investigators propose a randomized controlled trial of discontinuation versus
continuation of annual mass azithromycin distribution in hypoendemic communities of Maradi,
Niger. The investigators will randomize communities with up to 20% Trachomatous Inflammation
- Follicular (TF) prevalence following at least 5 years of mass azithromycin distribution to
discontinuation or continuation of 3 additional years of annual mass azithromycin
distribution.